-
1تقرير
المساهمون: Ali Aminian, Director of Bariatric and Metabolic Institute
المصدر: A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06374875Test
-
2تقرير
المصدر: FINErenone druG Utilization Study and Assessment of Temporal Changes Following Availability of Different Treatment Options in Patients With Chronic Kidney Disease and Type 2 Diabetes
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05526157Test
Other URLs: https://clinicaltrials.bayer.comTest/
-
3تقرير
المصدر: Comparative Cardiovascular and Renal Effectiveness and Safety of Empagliflozin and Other SGLT2i in Patients With Type 2 Diabetes (T2D) With and Without Baseline Kidney Disease in the United States
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05465317Test
Other URLs: https://www.mystudywindow.comTest
-
4تقرير
المساهمون: Rozalina G. McCoy, Principal Investigator
المصدر: Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05214573Test
-
5تقرير
المؤلفون: Hangzhou Sciwind Biosciences Co., Ltd.
المصدر: A Phase 2, Open-label, Randomised, Dose-Finding Study of XW003, Once-Weekly Human Glucagon-Like Peptide 1 Analogue, Compared With Once-Daily Liraglutide 3 mg in Adult Participants With Obesity
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05111912Test
-
6تقرير
المؤلفون: Guangdong Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Henan University of Science and Technology
المساهمون: Zhiguang Zhou, Director of The National Clinical Research Center for Metabolic Diseases, and Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Endocrinology, The Second Xiangya Hospital of Central South University.
المصدر: A Randomized Controlled, Open-label, Multi-center Study With 16-week Beinaglutide or Dulaglutide Assessing Effects on Glucose Control and Weight Loss in Type 2 Diabetes With Overweight or Obesity.
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05005741Test
-
7تقرير
المؤلفون: Hangzhou Sciwind Biosciences Co., Ltd.
المصدر: A Phase 1, Randomised, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of XW003 Injection in Healthy Adult Participants
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04389775Test
-
8تقرير
المصدر: Effects of Exenatide on Motor Function and the Brain
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03456687Test
-
9تقرير
المصدر: Holden SE, Morgan CL, Qo Q, Jenks-Jones S, BernER, Curr CJ. Healthcare resource utatn and related fancl costs assocted wh glucose lowerg wh eher exenate or basal sul: A retrospecte cohort study. Dbetes Obes Metab. 2017 Aug;19(8):1097-1105. do 10.1111/dom.12916. Epub 2017 Mar 31.
Evaluation of the Clinical and Economic Outcomes Associated With Exenatide Versus Basal Insulin in People With Type 2 Diabetesالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02987348Test
-
10تقرير
المساهمون: Christina Kruuse, MD, PhD, DMSc, consultant Neurologist, Associate Professor
المصدر: The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Patients
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02829502Test